TIVC — Tivic Health Systems Income Statement
0.000.00%
Last trade - 00:00- $3.01m
- $1.01m
- $0.78m
- 14
- 27
- 22
- 10
Annual income statement for Tivic Health Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.86 | 1.26 | 1.84 | 1.18 | 0.78 |
| Cost of Revenue | |||||
| Gross Profit | -0.225 | -0.038 | 0.299 | 0.287 | 0.002 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.06 | 8.53 | 11.9 | 9.42 | 6.44 |
| Operating Profit | -3.2 | -7.27 | -10.1 | -8.24 | -5.66 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.64 | -8.49 | -10.1 | -8.24 | -5.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.64 | -8.49 | -10.1 | -8.24 | -5.66 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.64 | -8.49 | -10.1 | -8.24 | -5.66 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.64 | -8.49 | -10.1 | -8.24 | -5.66 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -646 | -3,338 | -1,774 | -177 | -19.5 |
| Dividends per Share |